703956007: Avanafil (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Hydrolase inhibitor\Phosphodiesterase inhibitor\Phosphodiesterase 5 inhibitor\Avanafil

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Pyrimidine and/or pyrimidine derivative\Pyrimidine\Avanafil

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2015. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3011179013 Avanafil en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3011999015 Avanafil (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

792811000172119 avanafil fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)

792821000172112 avanafil nl Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Avanafil	Is a	Smooth muscle relaxant (substance)	true	Inferred relationship	Some
Avanafil	Is a	Phosphodiesterase 5 inhibitor	true	Inferred relationship	Some
Avanafil	Has disposition (attribute)	Phosphodiesterase 5 inhibitor (disposition)	true	Inferred relationship	Some
Avanafil	Is a	Chemical categorized functionally	false	Inferred relationship	Some
Avanafil	Is a	Enzyme inhibitor	false	Inferred relationship	Some
Avanafil	Is a	Vasodilator (substance)	true	Inferred relationship	Some
Avanafil	Is a	Pyrimidine	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Avanafil 50 mg oral tablet	Has active ingredient	False	Avanafil	Inferred relationship	Some
Product containing avanafil (medicinal product)	Has active ingredient	True	Avanafil	Inferred relationship	Some	1
Avanafil 100 mg oral tablet	Has active ingredient	False	Avanafil	Inferred relationship	Some
Avanafil 200 mg oral tablet	Has active ingredient	False	Avanafil	Inferred relationship	Some
Avanafil 50 mg oral tablet	Has active ingredient	False	Avanafil	Inferred relationship	Some	1
Avanafil 50 mg oral tablet	Has basis of strength substance (attribute)	True	Avanafil	Inferred relationship	Some	1
Avanafil 100 mg oral tablet	Has active ingredient	False	Avanafil	Inferred relationship	Some	1
Avanafil 100 mg oral tablet	Has basis of strength substance (attribute)	True	Avanafil	Inferred relationship	Some	1
Avanafil 200 mg oral tablet	Has active ingredient	False	Avanafil	Inferred relationship	Some	1
Avanafil 200 mg oral tablet	Has basis of strength substance (attribute)	True	Avanafil	Inferred relationship	Some	1
Avanafil 100 mg oral tablet	Has precise active ingredient	True	Avanafil	Inferred relationship	Some	1
Avanafil 50 mg oral tablet	Has precise active ingredient	True	Avanafil	Inferred relationship	Some	1
Avanafil 200 mg oral tablet	Has precise active ingredient	True	Avanafil	Inferred relationship	Some	1
Product containing avanafil in oral dose form (medicinal product form)	Has active ingredient	True	Avanafil	Inferred relationship	Some	1
Product containing only avanafil (medicinal product)	Has active ingredient	True	Avanafil	Inferred relationship	Some	1
Avanafil only product in oral dose form	Has active ingredient	True	Avanafil	Inferred relationship	Some	1

Reference Sets

Belgian subset for AllergyIntolerance, causative agent, drug